Evotec Stock
WKN 566480 | ISIN DE0005664809

Quote

  Bid Ask
Quote 13,546 13,587
Units 222 Units 221 Units
current/rel. spread 0,041 0,303%
Quote time 15/12/2017 21:59:55
Daily high/low (money) 14,315 13,28
Change compared with
previous day (bid)
-0,454 -3,24%
Last quote of the day 13,546 13,587

Price data

Stock exchange Stuttgart  
Last 13,607 110 Units
Price determination time 15/12/2017 20:52:05
Daily volume (Units) 120.602  
Daily high/low 14,19 13,375
Prev. day's price (14/12) 14,10  
Change day before -0,49 -3,50%
Yearly high/low 22,58 (04/10) 6,69 (08/02)
52 week high / low 22,58 (04/10) 6,69 (08/02)

Latest quotes

Quote time Bid Ask
15/12/2017 / 21:59:55 13,546 13,587
15/12/2017 / 21:59:54 13,545 13,587
15/12/2017 / 21:59:53 13,548 13,587
15/12/2017 / 21:59:52 13,547 13,587
15/12/2017 / 21:59:51 13,547 13,583
15/12/2017 / 21:59:50 13,548 13,583
Historical quotes on Evotec

Key performance figures

  1 week 1 month 3 months 1 year 3 years 5 years
Performance +3,40% +4,27% -27,62% +101,62% +294,63% +402,29%
Rel. performance onEurostoxx 50 +4,34% +2,22% -29,96% +88,31% +266,58% +358,75%
Rel. performance onTecDAX +2,79% -0,37% -35,61% +54,13% +191,79% +189,05%

Video

Evotec Key figures

  2017e 2016 2015 2014
PER 49,30 37,21 32,08 -
Earnings per share 0,29 0,20 0,13 -0,05
Dividend 0,00 0,00 0,00 0,00
Dividend yield in % 0,00 0,00 0,00 0,00

Additional key figures on Evotec

Evotec Master data

WKN 566480
ISIN DE0005664809
Symbol EVT
Exchange segment Open Market
Type of financial instrument Stock
Denomination EVOTEC
Index membership TecDAX CDAX KURSINDEX
Trading segment -
Trading hours 8 - 22 Uhr
Currency EUR
Sector and industry Chemical/Pharmaceutical/Health - Biotechnology
Number of shares 147.520.005
Market capitalisation 2 Mrd.

Evotec Peer group

Name WKN Price Change / previous day
BIOSTAGE INC COM USD.. A2AGPZ 0,054 +25,58%
DUSOLO FERTILIZERS I.. A2DUNY 0,143 +23,28%
AGENNIX AG I.A. A1A6XX 0,062 +21,57%
ADVANCED PROTEOME TH.. A0LEHE 0,023 +21,05%
CATALYST BIOSCIENCES.. A2DLUK 8,263 +11,78%
CLEVELAND BIOLABS IN.. A14M47 2,823 +11,23%

Evotec Corporate events

Date Corporate event
No entries found

Evotec in the profile

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology, inflammation and infectious diseases. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca, Roche and UCB. In addition, the Company has existing development partnerships and product candidates both in clinical and..

More information about Evotec can be found in the profile